Quick Access


Bu Dergi DOI ve Crosscheck üyesidir


Abstract


Iron Drug and Folic Acid Use Status in Pregnant Women and Affecting Factors

Purpose:The purpose of this research; The aim of this study was to determine the use of iron and folic acid in pregnant women who were admitted to the hospital for prenatal care. Method :This descriptive and cross-sectional study was carried out in 391 pregnant women who applied for antenatal care services at the Obstetrics and Gynecology outpatient clinic of Harran University, and accepted to participate in the study. The data of the study on socio - demographic and anemia were obtained by using the data collection form developed by the researcher based on the literature. After the data collection form was applied, blood samples were taken from the pregnant women for hemoglobin measurement and laboratory results were recorded. The recorded results were analyzed. Results: Of the participants, 79.0% were illiterate, 15.6% were primary and above, 5.4% were illiterate and 71.1% of the participants lived in the district. 99.5% of respondents did not work in any business this rate is 74.2% in the spouses of the participants. Participants; The mean age at first marriage was 17.8 ± 2.2, the mean number of living children was 4.6 ± 2.9, the rate of giving birth was 9.0%, the rate of miscarriage was 47.3%.The ratio of 53.2% of the pregnants in the second trimester was 39.8% in the last two pregnancies, less than 24 months.The rate of patients with anemia was 40.7% and the mean hemoglobin was 11.2 ± 1.5. 44.0% of the participants had received four or fewer antenatal care during pregnancy, 9.0% did not know that they should use iron medication, 41.9% did not use iron medication, 84.7% did not start using folic acid after the pregnancy, 66.8% of the pregnant women they did not use folic acid in the first three months and 23.5% stated that they did not know that they should use folic acid. When the education levels of the participants, family types, time between two pregnancies, use of regular iron medication, number of taking prenatal care and anemia were compared, the difference between them was statistically significant (p <0.05). Similarly, when the educational status of the participants and the number of prenatal care were taken and the use of folic acid in the first three months of pregnancy was compared, the difference between the groups was significant (p <0.05). When the hemoglobin values of the participants were compared between the two pregnancies, the difference between the groups was found to be significant in favor of those who were longer than 24 months (p <0.05). Similarly, when the number of antenatal care and hemoglobin levels were compared, the difference between them was statistically significant in favor of those receiving five or more caregivers (p <0.05). Result:In this study, the use and knowledge of folic acid and iron drug in women during pregnancy was found to be low. In addition, the use of periconceptional folic acid was found to be low. however, the number of prenatal care and the use of iron and folic acid increased in parallel. Prenatal care-promoting trainings, seminars etc. should be made public information activities.



Keywords
Iron drug, folic acid, pregnancy



References

Advanced Search


Announcements

    Systematic Impact Factor

    SMARTJOURNAL 

    Internation Scientific Indexing

    (ISI) tarafından

    indekslenmektedir.


    Internation Scientific Indexing (ISI)

    SMARTJOURNAL 

    Internation Scientific Indexing

    (ISI) tarafından

    indekslenmektedir.

    2017 Impact Factor: 0.834


    General Impact Factor

    SMARTJORUNAL General Impact Factor tarafından indekslenmektedir.


    Directory of Indexing and Impact Fact (DIIF)

    SMARTJOURNAL Directory of Indexing and Impact Fact (DIIF) tarafından indekslenmektedir.


    Society of Economics and Development

    SMARTJOURNAL Society of Economics and Development tarafından indekslenmektedir.


    Root Society for Indexing and Impact Factor Service

    Smart Journal Root Society for Indexing and Impact Factor Service tarafından indeklenmektedir.


    Scientific World Index ( SCIWIN)

    SMARTJOURNAL Scientific World Index ( SCIWIN) tarafından indekslenmektedir.


    Directory of Research Journals Indexing (DRJI)

    Smartjournal Directory of Research Journals Indexing (DRJI) tarafından indekslenmektedir.


    ResearchBible (Academic Resource Index)

    Smart Journal Dergisi ResearchBible (Academic Resource Index) tarafından indekslenmektedir.


    Eurasian Scientific Journal Index (ESJI)

    SMART Journal Eurasian Scientific Journal Index (ESJI) tarafından indekslenmektedir.



Address :İstanbul/Türkiye
Telephone :+90 543 373 80 81 (WhatsApp & GSM) Fax :
Email :editorsmartjournal@gmail.com

Web Yazılım & Programlama Han Yazılım Bilişim Hizmetleri